Effects of 12 Months' Treatment with Testosterone Undecanoate on Markers for Erythropoietic Activity and Safety Aspects in Transgender and Cisgender Hypogonadal Men.

Lethin, Kajsa; Aardal, Elisabeth; Lood, Yvonne; Ekman, Bertil; Wahlberg, Jeanette

Lethin, Kajsa; Aardal, Elisabeth; Lood, Yvonne; Ekman, Bertil; Wahlberg, Jeanette.

Affiliation

Lethin K; Department of Endocrinology in Linköping, Linköping University, Linköping, Sweden.
Aardal E; Department of Health, Medicine and Caring Sciences, Linköping University, Linköping, Sweden.
Lood Y; Department of Clinical Chemistry, Linköping University, Linköping, Sweden.
Ekman B; Department of Biomedical and Clinical Sciences, Linköping University, Linköping, Sweden.
Wahlberg J; Department of Biomedical and Clinical Sciences, Linköping University, Linköping, Sweden.

J Appl Lab Med ; 9(2): 223-236, 2024 Mar 01.

Article in En | MEDLINE | ID: mdl-38085088

Subject(s)

Testosterone; Transgender Persons; Female; Humans; Male; Cholesterol, HDL; Hemoglobins; Prospective Studies; Testosterone/analogs & derivatives

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Testosterone / Transgender Persons Limits: Female / Humans / Male Language: En Journal: J Appl Lab Med Year: 2024 Document type: Article Affiliation country: Sweden Country of publication: United kingdom

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google